UCSF

Tagged: drug discovery and development

Arkin receives Ono Pharma Foundation Breakthrough Science Initiative Award

Michelle Arkin, PhD, has received the 2018 Breakthrough Science Initiative Award from the Ono Pharma Foundation to study a class of proteins, called 14-3-3 proteins, known to be involved in various cancers, with the ultimate goal of enabling discoveries that lead to new ways to treat cancer.

UCSF School of Pharmacy joins data-sharing partnership to speed cancer drugs

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Computer models speed UCSF scientists toward psychiatric drug discoveries

For decades, scientists have wanted to be able to study dopamine receptors one by one. The brain’s dopamine receptors are responsible for a variety of behaviors, such as reward seeking, and are also involved in psychiatric illnesses like schizophrenia. There are five types of dopamine receptors, and psychiatric drugs usually affect multiple receptors at once, often producing debilitating or even dangerous side effects.

Matt Jacobson named chair of the Department of Pharmaceutical Chemistry

Renowned researcher and educator Matthew Jacobson, PhD, has been named the new chair of the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry. His appointment by Dean B. Joseph Guglielmo, PharmD, will be effective January 15, 2016.

Computer models successfully predict drug side effects

New computer models were able to successfully predict negative side effects for hundreds of currently marketed drugs, report researchers from the UCSF School of Pharmacy, SeaChange Pharmaceuticals, and Novartis Institutes for Biomedical Research in a paper published online this week in the journal Nature.

Michael Fischbach receives Packard Fellowship

Michael Fischbach, PhD, who studies drug-like molecules produced by human gut bacteria, has been awarded one the 16 prestigious 2011 Packard Fellowships in Science and Engineering.

The fellowship, which supports “highly creative professors early in their careers,” provides an unrestricted research grant of $875,000 over five years.

Kathy Giacomini cites increasing impact of quantitative pharmacology

Pharmaceutical companies will increasingly apply the predictive modeling of quantitative pharmacology to do more efficient drug development, says Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the UCSF Schools of Pharmacy and Me

UCSF Center for Quantitative Pharmacology kicks off with 2-day Mission Bay symposium

The new UCSF Center for Quantitative Pharmacology housed within the Department of Bioengineering and Therapeutic Sciences (BTS), a joint department of the Schools of Pharmacy and Medicine, will be inaugurated next week with a wide-ranging, 2-day conference, September 22 and 23, 2011 at William J. Rutter Center on UCSF’s Mission Bay campus.

Louis Cantilena new ACDRS course director

Louis R. Cantilena, Jr., MD, PhD, is the newly appointed course director of the American Course on Drug Development and Regulatory Sciences (ACDRS) effective summer 2011.

Michael Fischbach explains his search for antibiotic-producing bacteria in the human gut

The bacteria in the human gut that produce antibiotics are the focus of a US$1 million W. M. Keck Foundation grant being led by Michael Fischbach, PhD, a faculty member in the UCSF School of Pharmacy.

Pages